If you tell your doctor this, it helps them know what is going on and if they need to change your plan
Our poster highlights preclinical results for our monthly quintuple receptor (GLP-1, GIP, GCG, AMY, and CALC) agonist program, demonstrating extended PK/PD, superior effects on food intake and weight loss compared to retatrutide in DIO rats, with a profile designed to enable both best-in-class efficacy and improved tolerability
Appetite suppression peaks align differently with meal patterns
doi: 10.1038/mp.2010.80 127 MaesM.LeonardB
Preserves and Builds Muscle: Regular resistance exercise stimulates muscle protein synthesis
WEGOVY has been granted approval as a supplementary therapy along with a decreased calorie intake and increased physical activity to promote long-term weight control among adult patients who have an initial BMI 30 kg/m 2 (obesity) or 27 kg/m 2 (overweight) in combination with at least one comorbid condition associated with weight gain (such as dyslipidemia, hypertension, or type 2 DM)
